Raytheon's AEGIS Monopoly Is Real - But RTX's 38x Multiple Asks You to Trust It Perfectly

Headlines about defense contracts are supposed to make you want to buy defense stocks. Raytheon just won another award for its AEGIS fire control system - the brain of the U.S. Navy's missile defense network aboard Arleigh Burke-class destroyers. Competitors are reporting the base figure at around $271.5 million with option upside. It's the latest link in a chain of awards stretching back years: $76.4 million in 2023, $360 million in 2024, $185.8 million in December 2024, $213 million for Zumwalt-class combat systems in May 2026, and now this.

The story sounds like a moat. And it is. But a moat is not a buying argument when the stock already trades at 37.7 times trailing earnings - nearly double Lockheed Martin's 21.5x and more than twice Northrop Grumman's 17.3x.

The question isn't whether Raytheon's defense business is structurally compelling. It is whether RTX shares, up 18.1% year-to-date and sitting near their 52-week high of $221.34, still offer enough margin of safety for an investor who needs the dividend to compound, not just the headline.

The sole-source moat that actually matters

Here's what most readers skip over in the contract press releases: Raytheon is not merely the lowest bidder for AEGIS fire control. It is the only qualified source.

The Naval Sea Systems Command has explicitly stated this on the record. The MK 99 Fire Control System - the equipment that guides missiles to targets in the AEGIS Weapon System - is designed, manufactured, assembled, and tested exclusively by Raytheon Missiles and Defense. The FY23-27 program, estimated between $500 million and $1.5 billion, is a sole-source award under 10 U.S. Code 3204(a)(1). There is no competitor. There is no price war.

That is pricing power in its purest form. If a Navy destroyer needs its fire control system updated, modernized, or replaced, there is literally no one else to call. This is the kind of mission-critical, oligopolistic positioning that survives budget cycles, administration changes, and even recessions. Governments may argue about the size of the defense budget, but they don't competitively bid systems where there is only one manufacturer.

I believe this sole-source dynamic is the single strongest argument for RTX's defense segment. It is a TOLL stock - a toll road with a gun on it.

The defense spending regime is different this cycle

This isn't a normal budget cycle. The FY2026 defense budget came in at $848.3 billion in discretionary funding. Then the White House put a $1.5 trillion figure on the table for FY2027. The House Appropriations Committee unveiled a $1.07 trillion defense funding bill in June 2026 - the largest in U.S. history, a $234 billion increase from the prior year.

Whether the final number lands closer to $1 trillion or $1.5 trillion, the trajectory is clear: defense spending is accelerating. The drivers are not cyclical. Depleted stockpiles from conflicts in Ukraine and the Middle East need replenishing. Great-power competition with China in the Indo-Pacific requires fleet modernization. The AEGIS upgrade cycle is one small thread in a much larger rearmament effort.

RTX reported Q2 2026 sales of $24.7 billion, up 14 percent versus prior year, and up 16 percent organically. Defense contributed to 16% organic sales growth for the quarter - to $24.7 billion, up from $21.6 billion a year earlier. The company raised its full-year outlook for adjusted sales to $95-96 billion, adjusted EPS to $7.10-$7.25, and free cash flow to $8.5-8.75 billion. Company backlog of $289 billion, up 22% year over year, with $119 billion in the defense segment alone.

The Big Five prime contractors now carry a combined backlog of $846 billion. Lockheed Martin's backlog grew 38%, General Dynamics 32%, and RTX 22%. This is not a pulse - it's a multi-year revenue expansion cycle.

The dividend profile: durable but modest

RTX has raised its dividend for 24 consecutive years, with 23 consecutive years of growth. The trailing twelve-month dividend per share is $2.76, yielding 1.27%. The payout ratio sits at 50.2% of earnings, and free cash flow over the trailing twelve months is $10.98 billion.

From a durability standpoint, this is solid. A 50% payout ratio means the dividend has room to grow even if earnings dip in a down cycle. Free cash flow more than covers the $3.5 billion annual dividend obligation. The balance sheet shows $8.3 billion in cash against $105.8 billion in total debt - debt-to-equity of 54.9% - which is manageable for a capital-intensive industrial of this scale, though not pristine.

But here's the thing: 1.27% is not a retirement-income yield. This is not a stock you buy for current income. You buy it for dividend growth. Lockheed Martin, by contrast, yields 2.33% with 24 years of consecutive increases - almost double RTX's yield for a company with a comparable dividend growth pedigree.

If your portfolio needs current yield, RTX is not the answer. If it needs dividend compounding over a 15- to 20-year horizon, the starting yield matters less. A 1.27% yield growing 8-10% annually turns into a 5-6% yield on cost in a decade. The compounding math works - if the earnings power sustains it.

The valuation problem no press release fixes

This is where the story gets harder. RTX trades at $216.65, or 37.7 times trailing earnings and 45.7 times forward earnings. That is not a discount. That is not a fair-value number. That is a premium valuation that requires near-flawless execution for the next several years.

Compare that to the peer set:

• Lockheed Martin: 21.5x trailing PE, 14.0x EV/EBITDA, 2.33% yield
• Northrop Grumman: 17.3x trailing PE, 14.7x EV/EBITDA, 1.72% yield
• General Dynamics: 23.1x trailing PE, 16.1x EV/EBITDA, 1.62% yield
• RTX: 37.7x trailing PE, 22.2x EV/EBITDA, 1.27% yield

RTX is the most expensive of the Big Five on every valuation metric except enterprise value - and even there, at $321 billion, it is the second-largest after Boeing (which is trading at 88x earnings because of well-known aerospace program failures, not because of fundamental value).

Why does RTX trade at this premium? Collins Aerospace - the commercial aviation business acquired from United Technologies - gives RTX exposure to the aerospace aftermarket, which has been booming as global fleet utilization remains near record levels. The Q2 results showed Collins driving strong volume growth in both commercial original equipment and aftermarket parts and repairs. Defense is the headline, but commercial aviation is what's keeping margins expanding.

The market is paying for that diversification. The question is whether the multiple leaves enough room when the cycle turns, demand normalizes, or the defense build-out pace moderates. A 45.7x forward multiple means the stock is already assuming the raised 2026 guidance is delivered, 2027 keeps accelerating, and the growth trajectory never wavers.

What this means for your portfolio

I don't think individual contract awards should drive a buy decision at RTX's current valuation. The AEGIS sole-source position is genuine pricing power, the defense backlog is a multi-year tailwind, and the dividend is safe. Those are the facts. But the stock has already absorbed a great deal of that optimism.

From an income and risk/reward point of view, RTX makes more sense for investors who:

• Are comfortable with a sub-1.5% starting yield and are buying primarily for dividend growth over a long horizon
• Want exposure to the defense build-out cycle but also want commercial aviation diversification
• Can tolerate a premium valuation because they believe the execution risk is low given the sole-source nature of many programs

It makes less sense for investors who:

• Need current income and would be better served by Lockheed Martin or General Dynamics, which offer higher yields at lower multiples
• Want a defensive position with more margin of safety - RTX's EV/EBITDA of 22.2x is the highest among the Big Five primes
• Are uncomfortable with the idea that the stock has already rallied 18% year-to-date and is trading near its 52-week high

The bottom line

The AEGIS contract is real. The sole-source moat is real. The defense spending tailwind is real. What isn't guaranteed is that a 38x trailing multiple is the right entry point for the next decade of compounding.

I'd be watching RTX more closely if it were trading in the low 30s on earnings, or if a market correction pulled it back toward 30x. At that point, the pricing power, the backlog, and the dividend growth trajectory would be selling at something closer to a risk/reward price they deserve. Right now, you're not getting a discount. You're getting a premium product at a premium price.

That's not a sell signal. But it is a reason to be patient.